Kok P.-S.Lee K.Lord S.CHIH-HSIN YANGRosell R.Goto K.John T.Wu Y.-L.Mok T.S.K.Lee C.K.2021-04-232021-04-2320210169-5002https://www.scopus.com/inward/record.uri?eid=2-s2.0-85101508653&doi=10.1016%2fj.lungcan.2021.02.027&partnerID=40&md5=fea33a62b8d0169713e749bcf1bfeecahttps://scholars.lib.ntu.edu.tw/handle/123456789/557693Objectives: To assess the clinical utility of quantitative PCR (qPCR) assays, a routinely used test for detection of epidermal growth factor receptor (EGFR) mutation in circulating tumour DNA (ctDNA) in treatment-naive advanced lung cancer patients. MaterCirculating tumor DNA; ctDNA; EGFR; False negative; Quantitative PCR[SDGs]SDG3circulating tumor DNA; epidermal growth factor receptor; epidermal growth factor receptor kinase inhibitor; EGFR protein, human; epidermal growth factor receptor; protein kinase inhibitor; tumor marker; advanced cancer; Article; cancer chemotherapy; cancejournal article10.1016/j.lungcan.2021.02.027336475772-s2.0-85101508653